Name: VOICE

Full name: Value-based healthcare for Outcomes In breast and lung Cancer in Europe

Collaborating institutions: OSI Ezkerraldea-Enkarterri Cruces and OSI Donostialdea (Osakidetza).

Timeframe: July 2018 – December 2023

Description: The project is based on the Value-Based Healthcare (VBHC) model that proposes an innovative strategic framework aimed at guiding healthcare services in their re-organisation to provide patients with the highest value healthcare at the best cost, specifically in the case of breast and lung cancer.

This model combines three elements:

  • The implementation of systems to measure patient health outcome values: PROMs (Patient Reported Outcome Measures) reported directly by the patient on the state of their health; PREMs (Patient Reported Experience Measures), measuring the experience of the patient within the healthcare process; and the clinical-value results for the patient, such as survival or the toxicity of their treatments.
  • The organisation of the healthcare practice related to processes or clinical conditions.
  • Estimate of costs per patient during the entire healthcare process.

Objective: To assess the implementation process, the effectiveness of clinical practice and its impact on costs grouped by process for an intervention-based measurement of outcome values for patients with breast or lung cancer.

Secondary objectives:

  • Create a Europe-wide Hospital Community pioneering in the assessment of value-based health outcomes related to breast and lung cancer including the patient’s perspective.
  • Identify factors determining the implementation process of an intervention based on measuring outcome values for the patient, and in the organisation of healthcare by processes.
  • Analyse the effectiveness of an intervention based on measuring outcome values for patients in order to improve patient empowerment, shared decision-making, and physician-patient communication.
  • Assess the impact of an intervention based on measuring outcome values for patients on costs grouped by clinical process, and in the organisation of healthcare by processes.
  • Identify differences in the implementation outcomes, efficacy and impact on costs between organisations participating in the project at international level (benchmarking).
  • Integrate the measurement of value-based health outcomes in everyday clinical practice for organisations both systematically and extended over term.

Study design: This multicentre prospective study combines an implementation research component and an effectiveness component, using quantitative and qualitative methods for data collection and analysis. Analyses will be carried out at individual level (patient) and at organisational level (costs).

Results:

  • Analyse the effectiveness of an intervention based on measuring outcome values for patients in order to improve patient empowerment, shared decision-making, and physician-patient communication.
  • Assess the impact of an intervention based on measuring outcome values for patients on costs grouped by clinical process, and in the organisation of healthcare by processes.
  • Integrate the measurement of value-based health outcomes in everyday clinical practice for organisations both systematically and long term.

Rol: Kronikgune Institute coordinates and manages the Europe-wide network of 10 hospitals. It also participates by providing support to the Cruces and Donostia University Hospitals in the development of their activities. Moreover, it is the responsible for centralising the data and undertaking the qualitative and quantitative analysis, both in the Basque Country and the Community.

Participants:

  • Cruces University Hospital 
  • Donostia University Hospital 
  • 12 Octubre University Hospital 
  • Hospital Juan Ramón Jiménez
  • Institut Català d’Oncologia
  • Hospital Universitari de Bellvitge
  • Institut de Cancerologie de l’Ouest
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl – IRCCS
  • Instituto Português de Oncologia do Porto
  • OLV AALST
Roche Farma, S.A. y Roche Diagnostics S.L.U collaborates in the project VOICE or “Value based healthcare for patients with lung and breast Cancer” coordinated by Kronikgune Institute